Svendsen K, Leithe S, Trewin-Nybråten CB, Balto A, Nes LS, Meland A, Børøsund E, Kiserud CE, Reinertsen KV, Eriksen HR, Gjelsvik YM, Ursin G(2024) How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls? Cancers (Basel), 16(3) DOI 10.3390/cancers16030602, PubMed 38339359
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA(2024) Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial J Immunother Cancer, 12(1) DOI 10.1136/jitc-2023-007990, PubMed 38242720
Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE(2023) Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials Breast Cancer Res Treat, 204(2), 249-259 DOI 10.1007/s10549-023-07147-z, PubMed 38123789